Interaction between an 11βHSD1 gene variant and birth era modifies the risk of hypertension in Pima Indians

Hypertension

Volumn 44, Issue 5, 2004, Pages 681-688

  Franks, Paul W ^a   Knowler, William C ^a   Nair, Saras ^a   Koska, Juraj ^a   Lee, Yong Ho ^a   Lindsay, Robert S ^b   Walker, Brian R ^c   Looker, Helen C ^a   Permana, Paska A ^d   Tataranni, P Antonio ^a   Hanson, Robert L ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Epidemiology; Gene expression; Genetics; Nutrition

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1 GENE; ADULT; ALLELE; AMERICAN INDIAN; ARTICLE; BIRTH; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GENE; GENE CONTROL; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; INFANT; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MOLECULAR INTERACTION; MULTIVARIATE ANALYSIS; NEWBORN; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; ENVIRONMENT; ETHNOLOGY; GENE LINKAGE DISEQUILIBRIUM; GENETICS; LONGITUDINAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PEDIGREE; RISK; STATISTICAL MODEL; UNITED STATES;

11BETA HYDROXYSTEROID DEHYDROGENASE; HSD11B1 PROTEIN, HUMAN;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADULT; ARIZONA; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; ENVIRONMENT; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; INDIANS, NORTH AMERICAN; LINKAGE DISEQUILIBRIUM; LONGITUDINAL STUDIES; MALE; MODELS, STATISTICAL; OBESITY; PEDIGREE; RISK;

EID: 7244232607     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000144294.28985.d5     Document Type: Article

References (28)

1. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med. 2002;4:45-61.
2. Knowler WC, Williams RC, Pettitt DJ, Steinberg AG. Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. Am J Hum Genet. 1980;43:520-526.
3. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet. 2003;361:598-604.
4. Wareham NJ, Franks PW, Harding AH. Establishing the role of gene-environment interactions in the etiology of type 2 diabetes. Endocrinol Metab Clin North Am. 2002;31:553-566.
5. Redden DT, Allison DB. Nonreplication in genetic association studies of obesity and diabetes research. J Nutr. 2003;133:3323-3326.
6. Olson CM, Rennie D, Cook D, Dickersin K, Flanagin A, Hogan JW, Zhu Q, Reiling J, Pace B. Publication bias in editorial decision making. JAMA. 2002;287:2825-2828.
7. Lindsay RS, Wake DJ, Nair S, Bunt J, Livingstone DE, Permana PA, Tataranni PA, Walker BR. Subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab. 2003;88:2738-2744.
8. Seckl JR, Walker BR. Minireview: 11β-hydroxysteroid dehydrogenase type 1, a tissue-specific amplifier of glucocorticoid action. Endocrinology. 2001;142:1371-1376.
9. Walker BR, Connacher AA, Lindsay RM, Webb DJ, Edwards CRW. Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocrinol Metab. 1995;80:3155-3159.
10. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect 'Cushing's disease of the omentum'? Lancet. 1997;349:1210-1213.
11. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR, Mullins JJ. 11β-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA. 1997;94:14924-14929.
12. Morton NM, Holmes MC, Fievet C, Staels B, Tailleux A, Mullins JJ, Seckl JR. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem. 2001;276:41293-41300.
13. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ, Seckl JR. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1 deficient mice. Diabetes. 2004;53:931-938.
14. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS. A transgenic model of visceral obesity and the metabolic syndrome. Science. 2001;294:2166-2170.
15. Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC, Staels B, Seckl JR, Mullins JJ. Metabolic syndrome without obesity: hepatic overexpression of 11β-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci USA. 2004;101:7088-7093.
16. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest. 2003;112:83-90.
17. Wake DJ, Rask E, Livingstone DE, Soderberg S, Olsson T, Walker BR. Local and systemic impact of transcriptional upregulation of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J Clin Endocrinol Metab. 2003;88:3983-3988.
18. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi MC, Grino M. Expression of the mRNA coding for 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J Clin Endocrinol Metab. 2003;87:2701-2705.
19. Draper N, Echwald SM, Lavery GG, Walker EA, Fraser R, Davies E, Sorensen TIA, Astrap A, Adamski J, Hewison M, Connell JM, Pedersen O, Stewart PM. Association studies between microsatellite markers within the gene encoding human 11β-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism. J Clin Endocrinol Metab. 2002;87:4984-4990.
20. Nair S, Lee YH, Lindsay RS, Walker BR, Tataranni PA, Bogardus C, Baier L, Permana PA. The 11β-hydroxysteroid dehydrogenase type 1 gene: genetic polymorphisms are associated with type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle. Diabetologia. 2004;47:1088-1095.
21. Bennett PH, Burch TA, Miller M. Diabetes mellitus in American (Pima) Indians. Lancet. 1971;2:125-128.
22. Knowler WC, Bennett PH, Hamman RF, Miller M. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol. 1978;108:497-505.
23. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, Switzerland: World Health Organization: 1985. Technical report series No. 727.
24. Fulker DW, Cherny SS, Sham PC, Hewitt JK. Combined linkage and association sib-pair analysis for quantitative traits. Am J Hum Genet. 1999;64:259-267.
25. Hennekens CH, Buring JE. Epidemiology in Medicine. Boston, Mass: Little Brown & Co; 1987.
26. Franks PW, Bhattacharya S, Luan J, Montague C, Brennard C, Challis B, Brage S, Ekelund U, Middleberg RP, O'Rahilly S, Wareham NJ. Association between physical activity and blood pressure is modified by variants in the G-protein coupled receptor 10. Hypertension. 2004;43: 224-228.
27. Morton NM, Ramage L, Seckl JR. Down-regulation of adipose 11β-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: a potential adaptive mechanism counteracting metabolic disease. Endocrinology. 2004;145:2707-2712.
28. Lindsay RS, Hanson RL, Bennett PH, Knowler WC. Secular trends in birth weight, BMI, and diabetes in the offspring of diabetic mothers. Diabetes Care. 2000;23:1249-1254.